ArticleWorld journal of gastrointestinal pathophysiology2026
Occult constipation masking as irritable bowel syndrome with predominant diarrhea in Bangladeshi children.
Article in World journal of gastrointestinal pathophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOccult constipation (OC) is defined by the absence of classical symptoms of constipation on initial clinical history, despite objective evidence of fecal retention, such as the presence of hard stool on digital rectal examination or fecal impaction identified on plain abdominal radiography. It is frequently undiagnosed in children and presents with a diverse array of symptoms, such as abdominal pain and frequent defecation with mucoid feces. These symptoms are strikingly similar to irritable bowel syndrome (IBS) with diarrhea (IBS-D).
aimTo verify the hypothesis that OC may present with the features of IBS-D.
methodsThis is a prospective observational study that involves consecutive children who were referred to our center as primarily diagnosed with IBS-D (consistent with Rome IV criteria) by another physician and did not improve after at least three months of treatment. Patients presenting with red-flag symptoms suggestive of organic disease were excluded from the study. Patients who exhibited fecal impaction on a plain abdominal radiograph were diagnosed as OC and were administered magnesium hydroxide (milk of magnesia; 400 mg/5 mL) for a period of two months, with a progressive taper over the course of one month. Outcomes were assessed based on changes in pain intensity, frequency, and stool characteristics after the commencement of treatment.
resultsThis study included 54 patients who were diagnosed with IBS-D by other consultants and were unresponsive to treatment. Of these patients, 49 (91%) had OC mimicking IBS-D. After commencing treatment for OC, 46 (94%) of the 49 patients demonstrated a positive clinical response (44 good, 2 satisfactory).
conclusionChildren presenting with IBS-D related symptoms who are unresponsive to standard therapy may benefit from evaluation for OC before considering escalation to more invasive investigations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.